Article
Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapy.
Clinical lymphoma, myeloma & leukemia - 1 Aug 2013
Daver Naval, Liu Dumlao Theresa, Ravandi Farhad, Pierce Sherry, Borthakur Gautam, Pemmaraju Naveen, Nazha Aziz, Faderl Stefan, Jabbour Elias, Garcia-Manero Guillermo, Cortes Jorges, Kantarjian Hagop, Quintás-Cardama Alfonso
Abstract excerpt
BACKGROUND: The effect of prognostically important gene mutations (MUTs), nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1) and fms-related tyrosine kinase 3 (FLT3), in elderly patients with acute myeloid leukemia (AML) is not well defined. PATIENTS AND METHODS: We analyzed 557 patients, 65 years of age or older with newly diagnosed AML, treated at our institution between 2000 and 2010 with cytotoxic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
